Related Experiment Video
Updated: Jun 2, 2026
06:45
Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Multifunctional cationic host defence peptides and their clinical applications
Amy T Y Yeung1, Shaan L Gellatly, Robert E W Hancock
1Department of Microbiology and Immunology, Centre for Microbial Diseases and Immunity Research, University of British Columbia, Room 232, 2259 Lower Mall Research Station, Vancouver, BC, V6T 1Z4, Canada.
Cellular and Molecular Life Sciences : CMLS
|May 17, 2011
Summary
Novel antimicrobial peptides, known as cationic host defence peptides (HDPs), show promise for treating drug-resistant infections. These peptides exhibit both direct antimicrobial effects and immune-modulating properties, offering a new therapeutic avenue.
Area of Science:
- Microbiology and Immunology
- Drug Discovery and Development
Background:
- Increasing prevalence of multidrug-resistant bacterial strains necessitates novel antimicrobial therapies.
- Cationic host defence peptides (HDPs) and innate defence regulators (IDRs) offer a promising alternative to conventional antibiotics.
Purpose of the Study:
- To provide an overview of the antimicrobial and immunomodulatory activities of cationic HDPs.
- To discuss the potential of HDPs as therapeutic agents for infectious diseases.
Main Methods:
- Review of existing literature on cationic host defence peptides (HDPs).
- Analysis of studies detailing antimicrobial and immunomodulatory functions of HDPs.
Main Results:
- Cationic HDPs possess direct antimicrobial activity against a range of pathogens.
- HDPs are increasingly recognized for their diverse immunomodulatory properties.
- These dual activities position HDPs as multifunctional therapeutic candidates.
Conclusions:
- Cationic HDPs represent a significant therapeutic potential for combating infectious diseases, particularly those caused by resistant pathogens.
- Their combined antimicrobial and immunomodulatory effects warrant further investigation for clinical applications.
Related Concept Videos
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:20Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:25Colonisation of Pathogens
Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...